Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Mast cell–derived particles deliver peripheral signals to remote lymph nodes
Christian A. Kunder1,
Ashley L. St. John2,
Guojie Li1,
Kam W. Leong3,
Brent Berwin6,
Herman F. Staats1,2,4, , and
Soman N. Abraham1,2,5,7
1 Department of Pathology, 2 Department of Immunology, 3 Department of Biomedical Engineering, 4 Department of Medicine, and 5 Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710 6 Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, NH 03755 7 Duke–National University of Singapore, Graduate Medical School, Singapore 169857
CORRESPONDENCE Soman N. Abraham: soman.abraham{at}duke.edu
Abstract:
During infection, signals from the periphery are known to reachdraining lymph nodes (DLNs), but how these molecules, such asinflammatory cytokines, traverse the significant distances involvedwithout dilution or degradation remains unclear. We show thatperipheral mast cells, upon activation, release stable submicrometerheparin-based particles containing tumor necrosis factor andother proteins. These complexes enter lymphatic vessels andrapidly traffic to the DLNs. This physiological drug deliverysystem facilitates communication between peripheral sites ofinflammation and remote secondary lymphoid tissues.
C.A. Kunder and A.L. St. John contributed equally to this paper.
Abbreviations: BMMC, BM-derived MC DLN, draining LN HEV, high endothelial venule MC, mast cell SEM, scanning electron micrograph
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Elizabeth M. Adler (3 November 2009) Sci. Signal.2 (95), ec352.
[DOI: 10.1126/scisignal.295ec352] |Abstract »
Interplay between Mast Cells and Lymphatic Vessels in Different Molecular Types of Breast Cancer.
M. RAICA, A. M. CIMPEAN, R. CEAUSU, D. RIBATTI, and P. GAJE (2013)
Anticancer Res
33, 957-963
|Abstract »|Full Text »|PDF »
The FcR{beta}- and {gamma}-ITAMs Play Crucial but Distinct Roles in the Full Activation of Mast Cells Induced by IgE{kappa} and Protein L.
S. Nunomura, Y. Kawakami, T. Kawakami, and C. Ra (2012)
J. Immunol.
188, 4052-4064
|Abstract »|Full Text »|PDF »
Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension.
F. Perros, P. Dorfmuller, D. Montani, H. Hammad, W. Waelput, B. Girerd, N. Raymond, O. Mercier, S. Mussot, S. Cohen-Kaminsky, et al. (2012) 185, 311-321
|Abstract »|Full Text »|PDF »
Coordinated Regulation of Lymph Node Vascular-Stromal Growth First by CD11c+ Cells and Then by T and B Cells.
S. Chyou, F. Benahmed, J. Chen, V. Kumar, S. Tian, M. Lipp, and T. T. Lu (2011)
J. Immunol.
187, 5558-5567
|Abstract »|Full Text »|PDF »
Mast cell modulation of the vascular and lymphatic endothelium.
C. A. Kunder, A. L. St John, and S. N. Abraham (2011)
Blood
118, 5383-5393
|Abstract »|Full Text »|PDF »
Serglycin: A Structural and Functional Chameleon with Wide Impact on Immune Cells.
M. Zhu, Y. Yang, Y. Wang, Z. Wang, and Y.-X. Fu (2011)
J. Immunol.
186, 7156-7163
|Abstract »|Full Text »|PDF »
p66Shc Is a Negative Regulator of Fc{varepsilon}RI-Dependent Signaling in Mast Cells.
C. Ulivieri, D. Fanigliulo, G. Masi, M. T. Savino, A. Gamberucci, P. G. Pelicci, and C. T. Baldari (2011)
J. Immunol.
186, 5095-5106
|Abstract »|Full Text »|PDF »
Mast Cell-Derived IL-10 Suppresses Germinal Center Formation by Affecting T Follicular Helper Cell Function.
R. Chacon-Salinas, A. Y. Limon-Flores, A. D. Chavez-Blanco, A. Gonzalez-Estrada, and S. E. Ullrich (2011)
J. Immunol.
186, 25-31
|Abstract »|Full Text »|PDF »